Literature DB >> 19720606

Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension.

Vincent Mainguy1, François Maltais, Didier Saey, Philippe Gagnon, Simon Martel, Mathieu Simon, Steeve Provencher.   

Abstract

BACKGROUND: A majority of patients with idiopathic pulmonary arterial hypertension (IPAH) display persistent exercise intolerance despite new specific therapies. Whether patients with IPAH exhibit peripheral muscle dysfunction that may contribute to this limitation remains unknown. The hypothesis that the muscles of patients with IPAH are weaker and display morphological changes compared with those of control subjects and that those changes partly correlate with their exercise capacity was tested.
OBJECTIVE: To characterise quadriceps function, morphology and the enzymatic profile of patients with IPAH.
METHODS: Exercise capacity, limb muscle cross-sectional area by CT scan, quadriceps strength by maximal voluntary contraction and non-volitional magnetic stimulation of the femoral nerve (quadriceps twitch; TWq), and muscle morphology and enzymatic profile by quadriceps biopsy of 10 patients with IPAH were compared with those of 10 matched controls subjects.
RESULTS: Patients with IPAH displayed a lower proportion of type I muscle fibres (p=0.05), a lower maximal voluntary contraction (p=0.05) and TWq (p=0.01), and an increased muscular phosphofructokinase/3-hydroxyacyl-CoA-dehydrogenase ratio (p=0.05). They also tended to have lower thigh muscle cross-sectional area (p=0.15). Maximal oxygen uptake correlated with quadriceps strength (R(2)=0.42, p=0.04), and oxygen uptake at anaerobic threshold correlated with muscle oxidative capacity assessed by oxidative enzyme level for citrate synthase (R(2)=0.45, p=0.05) and 3-hydroxyacyl-CoA-dehydrogenase (R(2)=0.86, p<0.01), and type I fibre capillarity (R(2)=0.57, p=0.02).
CONCLUSION: Patients with IPAH present significant peripheral muscle changes that partly correlated with their exercise capacity.

Entities:  

Mesh:

Year:  2009        PMID: 19720606     DOI: 10.1136/thx.2009.117168

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  40 in total

Review 1.  Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?

Authors:  Marios Panagiotou; Andrew J Peacock; Martin K Johnson
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

Review 2.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

3.  Kinetics of skeletal muscle O2 delivery and utilization at the onset of heavy-intensity exercise in pulmonary arterial hypertension.

Authors:  Priscila B Barbosa; Eloara M V Ferreira; Jaquelina S O Arakaki; Luciana S Takara; Juliana Moura; Rúbia B Nascimento; Luiz E Nery; J Alberto Neder
Journal:  Eur J Appl Physiol       Date:  2011-01-12       Impact factor: 3.078

4.  Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension.

Authors:  Simon Malenfant; François Potus; Frédéric Fournier; Sandra Breuils-Bonnet; Aude Pflieger; Sylvie Bourassa; Ève Tremblay; Benjamin Nehmé; Arnaud Droit; Sébastien Bonnet; Steeve Provencher
Journal:  J Mol Med (Berl)       Date:  2014-12-30       Impact factor: 4.599

5.  Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Gustavo A Heresi; Steven K Malin; Jarrod W Barnes; Liping Tian; John P Kirwan; Raed A Dweik
Journal:  Ann Am Thorac Soc       Date:  2017-02

Review 6.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

7.  The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension.

Authors:  Hans-Joachim Kabitz; Hinrich-Cordt Bremer; Anja Schwoerer; Florian Sonntag; Stephan Walterspacher; David Johannes Walker; Nicola Ehlken; Gerd Staehler; Wolfram Windisch; Ekkehard Grünig
Journal:  Lung       Date:  2013-12-13       Impact factor: 2.584

8.  Regional skeletal muscle remodeling and mitochondrial dysfunction in right ventricular heart failure.

Authors:  Rob C I Wüst; David S Myers; Rachel Stones; David Benoist; Philip A Robinson; John P Boyle; Chris Peers; Ed White; Harry B Rossiter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

9.  Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension.

Authors:  Irina Enache; Anne-Laure Charles; Jamal Bouitbir; Fabrice Favret; Joffrey Zoll; Daniel Metzger; Monique Oswald-Mammosser; Bernard Geny; Anne Charloux
Journal:  Mol Cell Biochem       Date:  2012-10-26       Impact factor: 3.396

10.  Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Emmy Manders; Peter I Bonta; Jaap J Kloek; Petr Symersky; Harm-Jan Bogaard; Pleuni E Hooijman; Jeff R Jasper; Fady I Malik; Ger J M Stienen; Anton Vonk-Noordegraaf; Frances S de Man; Coen A C Ottenheijm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.